BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2839215)

  • 21. [Long term results of the treatment of hemochromatosis by repeated bloodletting. Apropos of the article of F. Darnis, A. Mossé and collaborators].
    Conte M; Bodin F
    Ann Med Interne (Paris); 1971 Dec; 122(12):1211-2. PubMed ID: 4339574
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatocellular carcinoma: incidental finding in cirrhotic explanted livers.
    Caroli-Bottino A; Nascimento CM; Basto S; Ribeiro J; Silveira V; Carvalho AM; Castro PN; Villela-Nogueiro CA; Pannain VL
    Transplant Proc; 2005; 37(6):2791-2. PubMed ID: 16182811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.
    Niederau C; Fischer R; Sonnenberg A; Stremmel W; Trampisch HJ; Strohmeyer G
    N Engl J Med; 1985 Nov; 313(20):1256-62. PubMed ID: 4058506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis of liver cirrhosis: results of a 14-year-long clinical follow-up study].
    Marosi L; Ferenci P; Dragosics B; Kiss F; Pollak C; Minar E
    Schweiz Med Wochenschr; 1983 Oct; 113(43):1586-92. PubMed ID: 6316488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term prognosis of chronic B and C viral hepatitis].
    Ohlen J; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation for malignant diseases: selection and pattern of recurrence.
    Margarit C; Charco R; Hidalgo E; Allende H; Castells L; Bilbao I
    World J Surg; 2002 Feb; 26(2):257-63. PubMed ID: 11865357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature.
    Goh J; Callagy G; McEntee G; O'Keane JC; Bomford A; Crowe J
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):915-9. PubMed ID: 10514128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
    Mwangi J; Gatei DG
    East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of small nodular lesions in heavy drinkers.
    Suzuki M; Maeyama S; Nishikawa K; Okuse N; Hashizume K; Mamada Y; Kobayashi Y; Okuse C; Takahashi Y; Osada T; Hayashi T; Yotuyanagi H; Suzuki H; Ogata S; Uchikoshi T; Iino S
    Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):55S-62S. PubMed ID: 12198376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma.
    Szczepański W
    Pol J Pathol; 1997; 48(3):147-57. PubMed ID: 9401407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of ultrasound-guided cytopuncture in the diagnosis of tumors in cirrhosis. Study of 29 cases].
    Messner M; Deugnier Y; Bernard-Griffiths I; Delamaire D; Estable P; Friguet JL; Le Gall M; Brissot P; Bourel M
    Gastroenterol Clin Biol; 1985 Jan; 9(1):42-6. PubMed ID: 3979726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.
    Abdel-Wahab M; Sultan A; el-Ghawalby A; Fathy O; el-Ebidy G; Abo-Zeid M; Aboel-Enin A; Abdallah T; Fouad A; el-Fiky A; Gadel-Hak N; Ezzat F
    Hepatogastroenterology; 2001; 48(39):757-61. PubMed ID: 11462920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aflatoxins in liver biopsies from Kenya.
    De Vries HR; Lamplugh SM
    Trop Geogr Med; 1989 Jan; 41(1):26-30. PubMed ID: 2548310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis.
    Britto MR; Thomas LA; Balaratnam N; Griffiths AP; Duane PD
    Scand J Gastroenterol; 2000 Aug; 35(8):889-93. PubMed ID: 10994630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of liver transplantation in hereditary hemochromatosis.
    Dar FS; Faraj W; Zaman MB; Bartlett A; Bomford A; O'Sullivan A; O'Grady J; Heneghan M; Rela M; Heaton ND
    Transpl Int; 2009 Jul; 22(7):717-24. PubMed ID: 19490544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma following neonatal hepatitis.
    Moore L; Bourne AJ; Moore DJ; Preston H; Byard RW
    Pediatr Pathol Lab Med; 1997; 17(4):601-10. PubMed ID: 9211553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study.
    Makino Y; Shiraki K; Sugimoto K; Ito T; Yamanaka T; Fujikawa K; Takase K; Nakano T
    Anticancer Res; 2000; 20(5C):3709-15. PubMed ID: 11268443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.